Actively Recruiting
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
Led by Aventyn, Inc. · Updated on 2024-03-20
1000
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
Sponsors
A
Aventyn, Inc.
Lead Sponsor
T
TwinEpidemic
Collaborating Sponsor
AI-Summary
What this Trial Is About
Heart failure is a syndrome that is defined by distinctive clinical, hemodynamic, and neurohormonal findings. HF represents a final common pathway for many different cardiovascular diseases, including coronary disease, hypertension, Valvular disease, and many primary heart muscle diseases. Clinically, HF patients experience dyspnea, fatigue and diminished exercise tolerance, reflecting elevated left and/or right ventricular filling pressures and decreased cardiac output.
CONDITIONS
Official Title
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women over 18 years of age
- Hospitalized with a primary diagnosis of acute decompensated heart failure (ADHF) or acute myocardial infarction (MI)
- Heart failure diagnosis based on typical symptoms, signs, pulmonary congestion, elevated BNP or NT-pro BNP, or impaired cardiac function
- Acute MI diagnosis based on chest pain, arm pain, or shortness of breath with elevated Troponin and/or EKG changes requiring intervention or medical therapy
You will not qualify if you...
- Patients must provide informed consent before enrollment
- For Phase 2, only men and women 50 years or older with a positive COVID-19 antigen test and one other risk factor will be enrolled in the intervention arm
- For Phase 2, subjects must be randomized within 48 hours of a positive COVID-19 antigen test
- Patients deemed unreliable by the investigator for follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Multiple Locations
Phoenix, Arizona, United States, 85016
Actively Recruiting
Research Team
N
Navin Govind
CONTACT
S
Sharolynn Mclurg
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here